Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA

Phase 3

Completed

• Conditions: Nasopharyngeal Carcinoma
• Interventions: Radiation: Radiation Therapy

• Registration Number: NCT00535795
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

Phase III: Assess conventional RT w/ conventional Plus accelerated boost RT in the treatment of nasopharyngeal CA

Detailed Description

It's a phase III study to assess conventional Rad Therapy with conventional Plus accelerated boost Rad Therapy in the treatment of nasopharyngeal carcinoma.

Study Timeline

• Study Start: 2007-09
• Study First Submitted: 2007-09-24
• Study First Submitted QC: 2007-09-24
• Study First Posted: 2007-09-26
• Status Verified: 2011-12
• Primary Completion: 2015-09
• Study Completion: 2015-09
• Last Update Submitted: 2019-02-28
• Last Update Posted: 2019-03-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients with nasopharyngeal Carcinoma

Exclusion Criteria

• Patients with carcinoma other than histo-pathologically confirmed nasopharyngeal CA

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Radiation Therapy	Conventional Radiation Therapy (XRT), one fraction per day, from Sunday to Thursday every week.
2	Radiation Therapy	Conventional Plus accelerated boost Radiation Therapy (XRT), from Sunday to Thursday every week.

Primary Outcome Measures

Name	Time	Method
safety and efficacy	5 years

Trial Locations

Locations (1)

KFSH&RC; 🇸🇦 Riyadh, Saudi Arabia